Dr. Timothy Cloughesy, a prominent physician from UCLA Health, conducted the INDIGO clinical trial to evaluate the efficacy of Vorasidenib,…
Browsing: Brain Cancer
The results of the CRUX study, which focused on the safety and feasibility of the JAK stat inhibitor Ruxolitinib in…
At the (ASCO) 2023 conference, Dr. Manmeet Singh Ahluwalla discussed, researchers presented the final trial report on a phase 1…
Decoding Recurrent Brain Metastases: The Power of 18F-Fluciclovine PET This discusses the challenges in detecting recurrent brain metastases and…
iFrame is not supported! VAL-083: Dennis Brown [2022]: Key Facts To Consider Glioblastoma VAL-083, or it’s chemical name dianhydrogalactitol…
VAL-083: Dennis Brown [2022]: Key Facts To Consider Glioblastoma VAL-083, or it’s chemical name dianhydrogalactitol (val-083), is a compound…
In this edition of The Onco’Zine Brief Peter Hofland talks with Catherine Ivy, the Founder and President of the Ben…